Skip to main content

Table 1 Results of previous artemether-lumefantrine therapeutic efficacy studies recalculated in accordance with WHO recommendations

From: Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018

  PCR uncorrected 28-day efficacy PCR corrected 28-day efficacy
Year of study Year of publication Reference Site Publisheda Recalculatedb Publisheda Recalculatedb
2008–2010 2014 Tinto et al. [22] Nanoro 46.1 46.1 89.8 81.9
2009 2011 Siribié et al. [20] Banfora 66.7 66.7 90.5 87.5
2010–2012 2015 Sondo et al. [21] Nanoro 43.3 43.3 77.8 64.5
  1. aPublished results
  2. bRecalculated using WHO per protocol definition [7]